Beginning operations in late 2020, Andelyn Biosciences will be a Phase 3 compliant Good Manufacturing Practices (cGMP) clinical manufacturing facility producing gene therapy and cell-based products.
Andelyn Biosciencesᅢᄁ¬ツᆲ¬トᄁ unique business model leads to reinvestment into pioneering research conducted at the Abigail Wexner Research Institute at Nationwide Children's on a broad range of challenges affecting childrenᅢᄁ¬ツᆲ¬トᄁs health.
Andelyn Biosciences Address
1180 Arthur E. Adams Drive Columbus, OH United States